When to prescribe Atropine for myopia control

Atropine can be used for myopia control as a monotherapy or as an adjunct to an optical intervention – we discuss patient selection, atropine combination treatments, how to taper and when to stop.

阿托品复合的并发症

Most atropine currently prescribed for myopia control is compounded. How could this influence consistency of treatment and research results? What could current research lead to in future prescribing? Read more here.

Should I fit orthokeratology to a potential keratoconic?

MCS was hesitating fitting OrthoK to a patient who showed inferior corneal steepening. Her main concern was that OrthoK may induce corneal ecstasia/keratoconus in the future and whether there is a link between OrthoK and keratoconus.

Adult Myopia Progression

Adult Myopia Progression, and how to treat it

Adult myopia progression is frequently encountered in practice, yet we have almost no evidence base to guide management. Here we explore how often and how much myopia progression occurs in adulthood, and management options.

When to stop myopia control treatments

When to stop Myopia Control Treatments

Myopia control treatments can be tapered or stopped when it appears myopia progression is stabilizing.When should you stop myopia control treatments?

Thinking beyond myopia – managing the very high childhood myope

Children with more than 5-6D of myopia can require special consideration to ensure safe management of their ocular and systemic health. This clinical case details important aspects of care for the very high childhood myope: ophthalmology co-management, best optical corrections, parental education and eye health monitoring.

Managing a myopic anisometropic amblyopic child

This case is not your typical astigmatic myope. There are several features to this patient that require careful consideration, including high myopia, amblyopia, myopia correction and control, and eye health management.

AAO2019 Part 3 – Getting outside, Rebound and Barriers to Myopia Management

Welcome to the final instalment of myopia content from the American Academy of Optometry 2019 meeting. These updates continue from Part 2, which detailed Mark Bullimore and Noel Brennan’s fantastic session entitled Twelve Evidence Based Things That We Should Know About Myopia.

Baidu